Subclinical inflammation and renal allograft dysfunction: myth or reality?
Nephron · 2025
DOI: 10.1159/000544762 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephron, 2025. Verfasst von Carlos Couceiro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Bellvitge University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Kidney Transplantation, Inflammation.
Abstract (Originalsprache)
Since the implementation of the Banff classification, the diagnosis and treatment of transplant rejection has been standardized. However, the rigid categorization of transplant pathology has limited our perspective on allograft inflammation, particularly disregarding those inflammatory infiltrates who do not reach the category of rejection. The term subclinical inflammation was introduced to designate the inflammation found in protocol biopsies, without significant renal function deterioration. Following the introduction of modern immunosuppression with tacrolimus and mycophenolate, subclinical rejection rate decreased, and less attention was paid to this entity. However, in the last decades several studies have evaluated the impact of lower levels of inflammation and demonstrated its negative consequences on long-term outcomes. Although, in some patients this subclinical inflammation is not permanent and can spontaneously disappear. The uncomplete definition of subclinical inflammation, which only considered renal function stability, and the evaluation of the biopsy as a definitive diagnosis, and not as a picture of an evolving process are the main reasons why managing this inflammation represents a challenge, especially when there is no pathogenic mechanism identified. In this review, we revise the “natural” history of inflammation in the kidney allograft and its possible origins based on cellular composition and transcriptomic expression changes in kidney biopsies. In addition, we propose an updated definition and an approach to manage it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Department, Bellvitge University Hospital, Barcelona, Spain.
- Nephrology and Renal Transplantation Group, Infectious Disease and Transplantation Program, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain.
- Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
- Nephrology Department, Bellvitge University Hospital, Barcelona, Spain, jmcruzado@bellvitgehospital.cat.
- Nephrology and Renal Transplantation Group, Infectious Disease and Transplantation Program, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain, jmcruzado@bellvitgehospital.cat.
- Department of Clinical Sciences, University of Barcelona, Barcelona, Spain, jmcruzado@bellvitgehospital.cat.
Zitieren
APA
Couceiro, C., Visent, M., & Cruzado, J. M. (2025). Subclinical inflammation and renal allograft dysfunction: myth or reality?. Nephron. https://doi.org/10.1159/000544762
Vancouver
Couceiro C, Visent M, Cruzado JM. Subclinical inflammation and renal allograft dysfunction: myth or reality?. Nephron. 2025. doi:10.1159/000544762
BibTeX
@article{Couceiro2025,
author = {Couceiro, Carlos and Visent, Maria and Cruzado, Josep M},
title = {Subclinical inflammation and renal allograft dysfunction: myth or reality?},
journal = {Nephron},
year = {2025},
doi = {10.1159/000544762}
}
EUVIMED